Brain Tumor Center Offering Translational Research Grants
The Brain Tumor Center at the University of Cincinnati Neuroscience Institute announces its second Molecular Therapeutics Pilot Grant Program to accelerate basic and translational research of primary and metastatic brain tumors.
All UC faculty with 80% or greater FTE, including those based at Cincinnati Childrens Hospital Medical Center and the Cincinnati VA Medical Center, are eligible to apply.
Interested applicants may submit a Letter of Intent and NIH biosketch to Angel Hall by August 1, 2013. Read additional information in the Request for Proposal.
Questions can be directed to business manager Angel Hall at angel.hall@uchealth.com or 513-558-8646.
Tags
Related Stories
On-site training in Speech & Hearing Clinic sets UC’s programs apart
August 27, 2026
At the University of Cincinnati’s Speech & Hearing Clinic, Doctor of Audiology and Speech-Language Pathology graduate students gain real-world experience while providing free speech and hearing services to the community.
Funding expands UC research into weight gain side effects of bipolar medication
August 26, 2026
University of Cincinnati researchers have been approved for funding by the Patient-Centered Outcomes Research Institute (PCORI) to expand the implementation of healthy lifestyle interventions and metformin prescription to help manage weight gain in overweight or obese youth taking second-generation antipsychotic medications.
One in four NFL players had CTE at death
August 25, 2026
Forbes cites research on concussions and football helmets by the University of Cincinnati in a report that found one in four NFL players had brain damage at death.